TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Caught with vials, Sector 52 resident gets 10-year RI

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Advertisement

Chandigarh, July 12

Advertisement

A local court has sentenced a city resident to undergo 10 years of rigorous imprisonment (RI) in a case registered under the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

The court has also imposed a fine of Rs 1 lakh on the convict, Vishal, alias Shankar, a resident of Sector 52.

As per the prosecution, the police had recovered 21 injections of buprenorphine from the accused during a checking in Sector 53 on August 26, 2018. The police claimed that the accused failed to produce any valid permit or licence for the injections.

Advertisement

The counsel for the accused claimed that he was falsely implicated in the case. He also said there was no compliance of Section 50 of the NDPS Act and no gazetted officer was present at the time of the alleged recovery.

Sunil Dutt, the public prosecutor, said the prosecution proved the case beyond a shadow of doubt.

After hearing of the arguments, the court held the accused guilty under Section 22 of the NDPS Act for possessing banned injections without any permit or licence and pronounced the sentence.

Advertisement
Show comments
Advertisement